Zenas BioPharma officer granted options, ESPP shares
Zenas BioPharma, Inc. reported that officer Joseph L. Farmer received equity-based compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Zenas BioPharma, Inc. reported that officer Joseph L. Farmer received equity-based compensation. He was granted stock options for 175,000 shares of common stock at an exercise price of $18.71 per share, expiring on June 15, 2036, and acquired 974 shares of common stock through the 2024 Employee Stock Purchase Plan at $13.35 per share.
Insider Trade Summary
Grant/Award: 175,974 shares
Grant/Award
2 txns
Insider
Farmer Joseph L
Role
See Remarks
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 175,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 974 | $13.35 | $13K |
Holdings After Transaction:
Stock Option (Right to Buy) — 175,000 contracts (Direct);
Common Stock — 974 shares (Direct)
Footnotes (2)
- F1. Common Stock acquired under Zenas BioPharma, Inc.'s 2024 Employee Stock Purchase Plan on February 5, 2026 in transactions that were exempt under Rule 16b-3(c).
- F2. The option vests as to 25% of the underlying shares of common stock on June 15, 2027, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal monthly installments over 36 months thereafter, subject to continued service.
Key Figures
Stock options granted: 175,000 options
Option exercise price: $18.71 per share
Option expiration: June 15, 2036
+4 more
7 metrics
Stock options granted
175,000 options
Grant on June 15, 2026 for common stock
Option exercise price
$18.71 per share
Exercise price of stock options
Option expiration
June 15, 2036
Expiration date of granted options
ESPP shares acquired
974 shares
Common Stock under 2024 Employee Stock Purchase Plan
ESPP purchase price
$13.35 per share
Price for ESPP acquisition on February 5, 2026
Common shares held
974 shares
Total direct common stock holdings after ESPP purchase
Underlying option shares
175,000 shares
Common stock underlying granted options
Key Terms
Employee Stock Purchase Plan, Rule 16b-3(c), vesting commencement date, equal monthly installments
4 terms
Employee Stock Purchase Plan financial
"Common Stock acquired under Zenas BioPharma, Inc.'s 2024 Employee Stock Purchase Plan on February 5, 2026"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
Rule 16b-3(c) regulatory
"transactions that were exempt under Rule 16b-3(c)"
An SEC rule that lets corporate insiders avoid automatic "short‑swing" profit recovery when they buy or sell their company’s stock under a pre‑approved, written plan that meets specific conditions. For investors, it matters because it clarifies when insider trades are treated as routine, reducing legal uncertainty and helping distinguish trades made for ordinary compensation or pre‑planned reasons from those that might signal opportunistic or timely insider advantage.
vesting commencement date financial
"the first anniversary of the vesting commencement date"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
equal monthly installments financial
"and as to the remaining shares, in equal monthly installments over 36 months thereafter"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Zenas BioPharma (ZBIO) report for Joseph L. Farmer?
Zenas BioPharma reported that officer Joseph L. Farmer received a grant of stock options and ESPP shares. He was awarded options on 175,000 shares and acquired 974 common shares through the company’s 2024 Employee Stock Purchase Plan.
How many stock options did Joseph L. Farmer receive at Zenas BioPharma (ZBIO)?
Joseph L. Farmer received stock options covering 175,000 shares of Zenas BioPharma common stock. These options carry an exercise price of $18.71 per share and expire on June 15, 2036, subject to the vesting schedule described.
What is the exercise price and expiration date of the ZBIO options granted to Joseph L. Farmer?
The options granted to Joseph L. Farmer have an exercise price of $18.71 per share and expire on June 15, 2036. Vesting is staged over four years, beginning one year after the vesting commencement date.
How do the stock options granted to Joseph L. Farmer at Zenas BioPharma (ZBIO) vest?
The options vest 25% of the underlying shares on June 15, 2027, the first anniversary of the vesting commencement date. The remaining shares vest in equal monthly installments over 36 months, contingent on continued service with the company.
What common stock did Joseph L. Farmer acquire under Zenas BioPharma (ZBIO) ESPP?
Joseph L. Farmer acquired 974 shares of Zenas BioPharma common stock under the 2024 Employee Stock Purchase Plan at $13.35 per share. The filing notes these ESPP transactions were exempt under Rule 16b-3(c) of the securities regulations.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates